The Effect of PEG Molecular Weights on Dissolution Behavior of Simvastatin in Solid Dispersions

Overview

Journal Iran J Pharm Res

Publisher Brieflands

Specialty Pharmacology

Date 2013 Nov 20

PMID 24250667

Citations 16

Authors

Noushin Bolourchian

Mohammad Mehdi Mahboobian

Simin Dadashzadeh

Affiliations

Soon will be listed here.

Abstract

The purpose of the present study was to investigate the effect of polyethylene glycol (PEG) molecular weights (6000, 12000 and 20000) as solid dispersion (SD) carriers on the dissolution behavior of simvastatin. SDs with various drug : carrier ratios were prepared by solvent method and evaluated for dissolution rate. Differential scanning calorimetry (DSC), X-ray diffraction (XRD), infrared spectroscopy and solubility studies were also performed on the optimum SD formulation. Samples prepared with all three types of PEG showed improved drug dissolution compared to intact drug and corresponding physical mixtures. Meanwhile, the best result was obtained by PEG 12000 with drug : carrier ratio of 1:7 which showed a 3-fold increase in dissolution rate compared to the intact drug. Based on DSC and XRD, no crystalline change occurred during the sample preparation. Solubility studies revealed that increasing the PEG molecular weight resulted in higher phase solubility of drug. In addition, saturated solubility of the optimum SD was significantly higher than that of intact drug and the related physical mixture (24.83, 8.74 and 8.88 μg/mL, respectively) that could be due to the decreased particle size and aggregation. The results confirmed the influence of PEG molecular weight on drug dissolution rate from solid dispersion systems.

Citing Articles

Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases.

Wykoff C, Kuppermann B, Regillo C, Chang M, Hariprasad S, Duker J J Vitreoretin Dis. 2024; 8(5):577-586.

PMID: 39318989 PMC: 11418737. DOI: 10.1177/24741264241267065.

PEGylated Micro/Nanoparticles Based on Biodegradable Poly(Ester Amides): Preparation and Study of the Core-Shell Structure by Synchrotron Radiation-Based FTIR Microspectroscopy and Electron Microscopy.

Makharadze D, Kantaria T, Yousef I, Del Valle L, Katsarava R, Puiggali J Int J Mol Sci. 2024; 25(13).

PMID: 39000109 PMC: 11241343. DOI: 10.3390/ijms25136999.

PEG4000 modified liposomes enhance the solubility of quercetin and improve the liposome functionality: in vitro characterization and the cellular efficacy.

Demirbolat G, Erdogan O, Coskun G, Cevik O Turk J Chem. 2023; 46(4):1011-1023.

PMID: 37538767 PMC: 10395731. DOI: 10.55730/1300-0527.3411.

Synthesis and Characterization of Ciprofloxacin Loaded Star-Shaped Polycaprolactone-Polyethylene Glycol Hydrogels for Oral Delivery.

Khodir W, Ismail M, Abd Hamid S, Daik R, Susanti D, Taher M Micromachines (Basel). 2023; 14(7).

PMID: 37512693 PMC: 10383659. DOI: 10.3390/mi14071382.

Stability-Enhanced Ternary Solid Dispersions of Glyburide: Effect of Preparation Method on Physicochemical Properties.

Barghi L, Vekalati A, Jahangiri A Adv Pharmacol Pharm Sci. 2023; 2023:2641153.

PMID: 37215486 PMC: 10199792. DOI: 10.1155/2023/2641153.

References

Chiou W, RIEGELMAN S . Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971; 60(9):1281-302. DOI: 10.1002/jps.2600600902. View

Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P . Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci. 2000; 10(4):311-22. DOI: 10.1016/s0928-0987(00)00084-1. View

Bashiri-Shahroodi A, Nassab P, Szabo-Revesz P, Rajko R . Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of meloxicam. Drug Dev Ind Pharm. 2008; 34(7):781-8. DOI: 10.1080/03639040801925735. View

Zhang Z, Bu H, Gao Z, Huang Y, Gao F, Li Y . The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm. 2010; 394(1-2):147-53. DOI: 10.1016/j.ijpharm.2010.04.039. View

Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D . Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm. 2004; 30(3):303-17. DOI: 10.1081/ddc-120030426. View

Laitinen R, Suihko E, Bjorkqvist M, Riikonen J, Lehto V, Jarvinen K . Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation. Drug Dev Ind Pharm. 2009; 36(5):601-13. DOI: 10.3109/03639040903386690. View

Leuner C, Dressman J . Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000; 50(1):47-60. DOI: 10.1016/s0939-6411(00)00076-x. View

Narang A, Srivastava A . Evaluation of solid dispersions of Clofazimine. Drug Dev Ind Pharm. 2002; 28(8):1001-13. DOI: 10.1081/ddc-120006431. View

Bley H, Fussnegger B, Bodmeier R . Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm. 2010; 390(2):165-73. DOI: 10.1016/j.ijpharm.2010.01.039. View

10.

de Waard H, Hinrichs W, Visser M, Bologna C, Frijlink H . Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm. 2007; 349(1-2):66-73. DOI: 10.1016/j.ijpharm.2007.07.023. View

11.

Newa M, Bhandari K, Kim J, Im J, Kim J, Yoo B . Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems. Chem Pharm Bull (Tokyo). 2008; 56(4):569-74. DOI: 10.1248/cpb.56.569. View

12.

Pathak D, Dahiya S, Pathak K . Solid dispersion of meloxicam: factorially designed dosage form for geriatric population. Acta Pharm. 2008; 58(1):99-110. DOI: 10.2478/v10007-007-0048-y. View

13.

Han H, Lee B, Lee H . Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation. Int J Pharm. 2011; 415(1-2):89-94. DOI: 10.1016/j.ijpharm.2011.05.055. View

14.

Okonogi S, Puttipipatkhachorn S . Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech. 2006; 7(2):E52. PMC: 2750279. DOI: 10.1208/pt070252. View

15.

Silva T, Arantes V, Resende J, Speziali N, de Oliveira R, Vianna-Soares C . Preparation and characterization of solid dispersion of simvastatin. Drug Dev Ind Pharm. 2010; 36(11):1348-55. DOI: 10.3109/03639041003801901. View

16.

Varshosaz J, Tavakoli N, Salamat F . Enhanced dissolution rate of simvastatin using spherical crystallization technique. Pharm Dev Technol. 2010; 16(5):529-35. DOI: 10.3109/10837450.2010.502175. View

17.

Janssens S, Denivelle S, Rombaut P, Van den Mooter G . Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends. Eur J Pharm Sci. 2008; 35(3):203-10. DOI: 10.1016/j.ejps.2008.06.014. View

18.

Craig D . The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002; 231(2):131-44. DOI: 10.1016/s0378-5173(01)00891-2. View

19.

Khan K . The concept of dissolution efficiency. J Pharm Pharmacol. 1975; 27(1):48-9. DOI: 10.1111/j.2042-7158.1975.tb09378.x. View

20.

Keck C, Muller R . Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2005; 62(1):3-16. DOI: 10.1016/j.ejpb.2005.05.009. View